Your session is about to expire
← Back to Search
Mifepristone + 2 doses of misoprostol 800 mcg for Medical Abortion
Study Summary
This trial will test a new medical abortion regimen for women who are 71-84 days pregnant. They will take two doses of a medication (mifepristone and misoprostol) and then be monitored for side effects and efficacy.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the scope of participation in this clinical research project?
"Indeed, according to clinicaltrials.gov, this study is still seeking patients for enrollment. It was initially announced on October 7th 2022 and underwent its last edit on November 2nd of the same year. The research requires 171 recruits from 8 different medical sites."
Who is able to enroll in this experiment?
"This investigation seeks 171 individuals for medical abortion care between the ages of 11 and 55. To be considered, patients must: procure services at one of participating clinics; have an intrauterine pregnancy ranging from 71 to 77 days or 78-84 days in gestation; travel back to clinic for follow up appointments; own a mobile phone with messaging capacity; agree to documents confirming consent; abide by all research protocols and post treatment monitoring plans, as well as maintain good physical health."
What is the current tally of healthcare facilities offering this clinical trial?
"This research is conducted at the University of Hawaii in Honolulu, CHOICES Memphis Center for Reproductive Health located in Tennessee and Planned Parenthood North Central States situated in Saint Paul, Minnesota alongside 8 additional clinical sites."
Does this research project seek participants who are over fifty years of age?
"This clinical trial stipulates that persons between the ages of 11 and 55 are eligible to apply. Separately, 4 studies for younger applicants aged 18 years or below and 12 trials accommodating elderly patients who exceed 65 have been established."
Are there any historical accounts of Mifepristone + 2 doses of misoprostol 800 mcg being studied in a clinical capacity?
"Mifepristone combined with two doses of misoprostol 800 mcg was initially investigated at Ain Shams Maternity hospital in 2014. Subsequently, a total of 279 studies have concluded and 27 more are actively recruiting participants, the majority being located in Honolulu, Hawaii."
Is this research study currently open to recruitment?
"Affirmative. According to the information located on clinicaltrials.gov, this medical trial is actively seeking participants. The study was initially published on October 7th 2022 and last edited November 2nd 2022; in total it needs 171 patients from 8 different locations."
What is the intended purpose of utilizing Mifepristone in conjunction with two doses of misoprostol 800 mcg?
"Mifepristone + 2 doses of misoprostol 800 mcg is typically employed to induce labor, but also has applications in the treatment of cushing syndrome, medical procedures and postpartum hemorrhage."
Is the Mifepristone + 2 doses of misoprostol 800 mcg regimen sanctioned by the FDA?
"The safety of Mifepristone + 2 doses of misoprostol 800 mcg has been established and is noted with a 3 on the risk scale. This drug combination currently holds approval status due to its phase 4 trial data."
Share this study with friends
Copy Link
Messenger